本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

138.61
-6.2700-4.33%
成交量:40.06万
成交额:5,655.64万
市值:89.69亿
市盈率:134.57
高:146.00
开:146.00
低:138.41
收:144.88
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:0.72
换手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:10.66
市盈率(LYR):-67.61

数据加载中...

2020/05/07

重要事件披露

8-K - Current report
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/03/18

重要事件披露

Current report, items 4.01 and 9.01
2020/03/10

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/10

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 2.02 and 9.01
2020/02/24

重要事件披露

Current report, items 5.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/03

重要事件披露

Current report, items 8.01 and 9.01
2019/11/27

重要事件披露

Current report, items 1.01 and 9.01
2019/11/20

SEC问询函

[Cover]Correspondence
2019/11/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01